Althea Medical

Company Overview

Snapshot

Founded in November 2020 by Lia Ofek and Rafi Benary, Althea Medical is a medical device startup with 1–10 employees. The company has raised $1.6M across five funding rounds from three investors. In January 2024, the company secured funding from Peregrine Ventures.

Business overview

Althea Medical is a medical device company focused on developing a minimally invasive, catheter-based solution for treating patients suffering from massive and sub-massive pulmonary embolism. The company's core technology is an over-the-wire system designed to combine the efficiency of large-bore thrombectomy with an easy-to-use delivery method, aiming to minimize patient risks. It features a mechanical clot removal system for capturing and removing thrombus bulk. Althea Medical operates within the Health Tech & Life Sciences sector, specifically targeting the Medical Devices industry and healthcare providers with solutions for medical treatment and therapeutics.

Strategic signal

In August 2023, Althea Medical was highlighted by CTech for its efforts to prevent pulmonary embolism, identified as a leading cause of preventable hospital deaths. This recognition underscores the critical need for innovative solutions in cardiovascular care and signals the potential impact of Althea Medical's technology on patient outcomes and healthcare efficiency.

Company Intelligence Q&A

What is Althea Medical's primary focus?

Althea Medical develops a catheter-based solution for treating patients with massive and sub-massive pulmonary embolism, aiming to provide a minimally invasive approach to this critical condition.

When was Althea Medical founded?

Althea Medical was founded in November 2020.

Who are the founders of Althea Medical?

Althea Medical was co-founded by Lia Ofek and Rafi Benary.

What is the status of Althea Medical?

Althea Medical is currently non-active, having ceased to operate in November 2025.